Open original FDA record ↗Recall record
- FDA identifier
- Z-1004-2023
- Company in FDA record
- Agfa Healthcare NV
- FDA classification date
- Jan 20, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
There is a software defect that can cause issues with images.
Source facts
- Action
- On December 5th, 2022, a customer letter ("Mandatory Product Correction Notification") was mailed to 40 United States of America affected consignees. The letter informed the customers about the issue and outlined the planned corrective actions. Acknowledgment, via email, that the information was received and understood was requested from the consignees. A Mandatory Service Bulletin was released to provide documentation to Agfa Healthcare services on how to deploy the correction for Enterprise Imaging XERO Viewer for the affected customer sites. Agfa HealthCare Service is reaching out to the affected customers to schedule and apply appropriate software correction.
- Initiated
- 2022-12-05
- Root cause
- Software design
- Distribution
- Distribution throughout US OUS distribution to Australia, Belgium, Brazil, Canada, Chile, Cyprus, France, Iceland, Ireland, Italy, Kenya, Luxembourg, Netherlands, Romania, Saudi Arabia, Spain, Sweden, United Kingdom, South Africa
- Recall number
- Z-1004-2023
- Recall status
- Open, Classified
- CDRH record ID
- 197566
- FDA classified
- 2023-01-20
- Recall event number
- 91357